S. H. Woolf, Screening for Prostate Cancer with Prostate-Specific Antigen ??? An Examination of the Evidence, New England Journal of Medicine, vol.333, issue.21, pp.1401-1405, 1995.
DOI : 10.1056/NEJM199511233332107

J. T. Isaacs, Role of Androgens in Prostatic Cancer, Vitam. Horm, vol.49, pp.433-502, 1994.
DOI : 10.1016/S0083-6729(08)61152-8

J. T. Isaacs, Androgen regulation of programmed death of normal and malignant prostatic cells, J. Androl, vol.13, pp.457-464, 1992.

M. Caine, Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia, Urol. Clin. North Am, vol.17, pp.641-649, 1990.

N. Kyprianou and C. M. Benning, Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis, Cancer Res, vol.60, pp.4550-4555, 2000.

C. M. Benning and N. Kyprianou, Quinazoline-derived alpha1- adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action, Cancer Res, vol.62, pp.597-602, 2002.

D. T. Price, Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate, J. Urol, vol.150, pp.546-551, 1993.

M. Takeda, &alpha;<sub>1</sub>- and &alpha;<sub>2</sub>-Adrenoceptors in BPH, European Urology, vol.36, issue.Suppl. 1, pp.31-34, 1999.
DOI : 10.1159/000052315

P. D. Walden, C. Gerardi, and H. Lepor, LOCALIZATION AND EXPRESSION OF THE alpha1A-1, alpha1B AND alpha1D-ADRENOCEPTORS IN HYPERPLASTIC AND NON-HYPERPLASTIC HUMAN PROSTATE, The Journal of Urology, vol.161, issue.2, pp.635-640, 1999.
DOI : 10.1016/S0022-5347(01)61986-4

R. Fukasawa, The alpha1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate, BJU International, vol.25, issue.5, pp.733-737, 1998.
DOI : 10.1097/00005392-199703000-00101

C. R. Chapple, -adrenoceptor subtypes in the human prostate, British Journal of Urology, vol.149, issue.5, pp.585-589, 1994.
DOI : 10.1111/j.1464-410X.1994.tb09188.x

URL : https://hal.archives-ouvertes.fr/hal-00576628

I. Marshall, R. P. Burt, C. , and C. R. , Signal Transduction Pathways Associated with &alpha;<sub>1</sub>-Adrenoceptor Subtypes in Cells and Tissues Including Human Prostate, European Urology, vol.36, issue.Suppl. 1, pp.42-47, 1999.
DOI : 10.1159/000052317

K. P. Minneman, Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+, Pharmacol. Rev, vol.40, pp.87-119, 1988.

M. I. Kotlikoff, G. Herrera, and M. T. Nelson, Calcium permeant ion channels in smooth muscle, Rev. Physiol. Biochem. Pharmacol, vol.134, pp.147-199, 1999.
DOI : 10.1007/3-540-64753-8_4

D. E. Clapham, L. W. Runnels, and C. Strubing, The trp ion channel family, Nature Reviews Neuroscience, vol.4, issue.6, pp.387-396, 2001.
DOI : 10.1038/35077544

R. Inoue, The Transient Receptor Potential Protein Homologue TRP6 Is the Essential Component of Vascular ??1-Adrenoceptor-Activated Ca2+-Permeable Cation Channel, Circulation Research, vol.88, issue.3, pp.325-332, 2001.
DOI : 10.1161/01.RES.88.3.325

V. A. Golovina, Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation, Am. J. Physiol. Heart Circ. Physiol, vol.280, pp.746-755, 2001.

M. J. Berridge, Calcium signalling and cell proliferation, BioEssays, vol.268, issue.6, pp.491-500, 1995.
DOI : 10.1002/bies.950170605

G. Grynkiewicz, M. Poenie, and R. Y. And-tsien, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem, vol.260, pp.3440-3450, 1985.

R. Skryma, current in human prostate cancer LNCaP cells: involvement in apoptosis, The Journal of Physiology, vol.90, issue.1, pp.71-83, 2000.
DOI : 10.1111/j.1469-7793.2000.00071.x

R. N. Skryma, Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: Involvement in cell proliferation, The Prostate, vol.322, issue.2, pp.112-122, 1997.
DOI : 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M

F. Vanden-abeele, Bcl-2-dependent modulation of Ca2+ homeostasis and store-operated channels in prostate cancer cells, Cancer Cell, vol.1, issue.2, pp.169-179, 2002.
DOI : 10.1016/S1535-6108(02)00034-X

H. Watanabe, Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives, Journal of Biological Chemistry, vol.277, issue.16, pp.13569-13577, 2002.
DOI : 10.1074/jbc.M200062200

M. Roudbaraki, Target cells of gamma3-melanocyte-stimu- lating hormone detected through intracellular Ca2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage, Endocrinology, vol.140, pp.4874-4885, 1999.

F. J. Braun, L. M. Broad, D. L. Armstrong, J. W. Putney, and . Jr, Stable Activation of Single Ca2+ Release-activated Ca2+ Channels in Divalent Cation-free Solutions, Journal of Biological Chemistry, vol.276, issue.2, pp.1063-1070, 2001.
DOI : 10.1074/jbc.M008348200

J. M. Diver, S. O. Sage, and J. A. Rosado, The inositol trisphosphate receptor antagonist 2-aminoethoxydiphenylborate (2-APB) blocks Ca2+ entry channels in human platelets: cautions for its use in studying Ca2+ influx, Cell Calcium, vol.30, issue.5, pp.323-329, 2001.
DOI : 10.1054/ceca.2001.0239

B. Lintschinger, Coassembly of Trp1 and Trp3 proteins generates diacylglycerol-and Ca2+-sensitive cation channels, J. Biol. Chem, vol.275, pp.27799-27805, 2000.

X. Zhu, M. Jiang, and L. Birnbaumer, Receptor-activated Ca2+ Influx via Human Trp3 Stably Expressed in Human Embryonic Kidney (HEK)293 Cells: EVIDENCE FOR A NON-CAPACITATIVE Ca2+ ENTRY, Journal of Biological Chemistry, vol.273, issue.1, pp.133-142, 1998.
DOI : 10.1074/jbc.273.1.133

T. Hofmann, Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol, Nature, vol.397, pp.259-263, 1999.

Y. Tesfai, H. M. Brereton, and G. J. Barritt, A diacylglycerol-activated Ca2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with expression of the TRP-6 (transient receptor potential) protein, Biochemical Journal, vol.358, issue.3, pp.717-726, 2001.
DOI : 10.1042/bj3580717

T. Okada, Molecular and Functional Characterization of a Novel Mouse Transient Receptor Potential Protein Homologue TRP7: Ca2+-PERMEABLE CATION CHANNEL THAT IS CONSTITUTIVELY ACTIVATED AND ENHANCED BY STIMULATION OF G PROTEIN-COUPLED RECEPTOR, Journal of Biological Chemistry, vol.274, issue.39, pp.27359-27370, 1999.
DOI : 10.1074/jbc.274.39.27359

R. J. Smith, Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C?dependent processes on cell responsiveness, J. Pharmacol. Exp. Ther, vol.253, pp.688-697, 1990.

L. A. Berven and G. J. Barritt, Evidence obtained using single hepatocytes for inhibition by the phospholipase C inhibitor U73122 of store-operated Ca2+ inflow, Biochemical Pharmacology, vol.49, issue.10, pp.1373-1379, 1995.
DOI : 10.1016/0006-2952(95)00050-A

Y. Mimura, Activation by .ALPHA.1-Adrenergic Agonists of the Progression Phase in the Proliferation of Primary Cultures of Smooth Muscle Cells in Mouse and Rat Aorta., Biological & Pharmaceutical Bulletin, vol.18, issue.10, pp.1373-1376, 1995.
DOI : 10.1248/bpb.18.1373

J. P. Noveral and M. M. Grunstein, Adrenergic receptor-mediated regulation of cultured rabbit airway smooth muscle cell proliferation, Am. J. Physiol, vol.267, pp.291-299, 1994.

B. B. Gao, B. L. Lei, Y. Y. Zhang, and Q. D. Han, Cell proliferation and Ca(2+)-calmodulin dependent protein kinase activation mediated by alpha 1A-and alpha 1B-adrenergic receptor in HEK293 cells, Acta Pharmacol. Sin, vol.21, pp.55-59, 2000.

K. T. Mcvary, K. E. Mckenna, L. , and C. , Prostate innervation, Prostate, vol.8, pp.2-13, 1998.

V. Rybalchenko, Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating, Mol. Pharmacol, vol.59, pp.1376-1387, 2001.

M. Naraghi, T. H. Muller, and E. Neher, Two-Dimensional Determination of the Cellular Ca2+ Binding in Bovine Chromaffin Cells, Biophysical Journal, vol.75, issue.4, pp.1635-1647, 1998.
DOI : 10.1016/S0006-3495(98)77606-4

A. Plonowski, Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207, Cancer Letters, vol.176, issue.1, pp.57-63, 2002.
DOI : 10.1016/S0304-3835(01)00734-0

C. Crescioli, Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells, The Prostate, vol.251, issue.1, pp.15-26, 2002.
DOI : 10.1002/pros.10028

J. B. Peng, CaT1 Expression Correlates with Tumor Grade in Prostate Cancer, Biochemical and Biophysical Research Communications, vol.282, issue.3, pp.729-734, 2001.
DOI : 10.1006/bbrc.2001.4638

U. Wissenbach, Expression of CaT-like, a Novel Calcium-selective Channel, Correlates with the Malignancy of Prostate Cancer, Journal of Biological Chemistry, vol.276, issue.22, pp.19461-19468, 2001.
DOI : 10.1074/jbc.M009895200

L. Tsavaler, M. H. Shapero, S. Morkowski, and R. Laus, Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins, Cancer Res, vol.61, pp.3760-3769, 2001.